Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase NA 23Phase 3 14Phase 1 11Phase 1/2 7Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 6Pancreatic Neoplasms 2Neoplasm Metastasis 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Radiotherapy 1Neoplasms 1Lung Neoplasms 1Gliosarcoma 1Glioblastoma 1Epidural Neoplasms 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4pembrolizumab 2Radiotherapy 2Radiosurgery 2Positron Emission Tomography Computed Tomography 2Ipilimumab 2Cyclophosphamide 2tislelizumab 1teprotumumab 1pazopanib 1lenvatinib 1gallium citrate 1fludarabine phosphate 1fludarabine 1evolocumab 1dexamethasone acetate 1dexamethasone 21-phosphate 1cabozantinib 1auricularum 1aldesleukin 1Spectrum Analysis 1Specimen Handling 1Pemetrexed 1Oxymorphone 1Oxycodone 1Nivolumab 1Morphine 1Levorphanol 1Lapatinib 1Hydromorphone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Neoplasm Metastasis × Radiosurgery × Clear all
NCT04895592 2026-05-14

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Emory University

Phase EARLY_PHASE1 Completed
26 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT05728372 2023-10-10

64Cu-DOTA Pembrolizumab for Imaging Metastatic Solid Tumors in Patients Receiving Stereotactic Body Radiation

City of Hope Medical Center

Phase EARLY_PHASE1 Withdrawn
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡